Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
Patents for C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
01/2011
01/04/2011CA2424754C Process for the preparation of bicyclic diketone salts
12/2010
12/29/2010EP2266951A1 Organic compounds
12/28/2010US7858613 Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs
12/23/2010WO2010082219A4 An arteether injection for treatment of malaria
12/23/2010US20100324094 Conformationally Restrained Epothilone Analogues as Anti-Leukemic Agents
12/22/2010CN101921252A 1-oxa-benzo-heterocycle compound, synthesis method and application thereof
12/22/2010CN101128436B Glycine derivative and use thereof
12/15/2010EP2261222A2 Erythromycins and process for their preparation
12/15/2010EP2261221A1 Epothilone analogues, their pharmaceutical compositions, their use and their preparations
12/14/2010US7851642 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amide compound
12/09/2010US20100311757 Salarins And Tulearins, Compositions And Uses Thereof
12/08/2010EP2257516A2 Methods of making cyclododecatriene and methods of making laurolactone
12/08/2010CN101910129A Synthesis of quaternary salt compounds
12/07/2010USRE41990 epothilone derivatives used for the treatment of cancer and cancers which have developed a multidrug-resistant phenotype; anticarcinogenic agents
12/02/2010US20100305339 Method for producing lactones from diols
12/01/2010EP2254880A2 Macrocyclic prodrug compounds useful as therapeutics
12/01/2010CN101903368A Process for preparing e-caprolactone
12/01/2010CN101903310A Process for producing organic compound and organic compound obtained by the same
11/2010
11/25/2010US20100298296 Oligomer-Tricyclic Conjugates
11/24/2010CN101891731A Method for synthesizing olopatatadine E-configurational isomer
11/23/2010US7838691 ATPase inhibitors; anticancer agents; synthesis and chemical intermediates thereto
11/17/2010CN101889006A Intermediates and methods for making zearalenone macrolide analogs
11/17/2010CN101889005A Intermediates in the synthesis of zearalenone macrolide analogs
11/17/2010CN101888997A Synthesis of quaternary salt compounds
11/16/2010US7834026 histone deacetylase inhibitors; antiproliferative; antineoplastic; thioredoxin (TRX)-mediated diseases such as autoimmune, allergy, inflammatory diseases; and neurodegenerative diseases; N-(2-Aminophenyl)-6-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)nicotinamide; hydroxamic acid moiety
11/11/2010WO2010127928A1 Insecticidal compounds
11/11/2010CA2759592A1 Insecticidal compounds
11/04/2010WO2010082219A3 An arteether injection for treatment of malaria
11/03/2010EP2244998A2 Elansolids, novel natural metabolites of flexibacter and antibiotically active derivatives thereof
11/02/2010USRE41911 Epothilone derivatives
11/02/2010US7825094 the sensitivity of cells typical of various proliferative disorders to the ansamycin CNF-101 ("17-AAG") is proportional to the HER-2 levels in those cells
11/02/2010CA2485201C Camptothecins with a modified lactone ring
10/2010
10/28/2010WO2010121877A2 Process for the preparation of olopatadine
10/28/2010WO2010080577A3 Oxepine modulators of h1 receptors and/or inhibitors of mast cell degranulation
10/28/2010WO2010078396A3 Compounds, intermediates, and methods of preparing the same
10/28/2010US20100273791 Tricyclic pyrazole derivatives as cannabinoid receptor modulators
10/27/2010EP2242359A1 Synthesis of resorcylic acid lactones useful as therapeutic agents
10/26/2010USRE41895 Epothilone derivatives
10/26/2010USRE41893 Epothilone derivatives
10/26/2010US7820713 Cocoa extracts as antioxidants
10/21/2010WO2010119274A1 Monomer, polymer, and method of making it
10/21/2010WO2010063659A3 Method for producing 1,6-hexanediol
10/20/2010EP1996571B1 Tetracyclic steroid derivatives useful as progesterone receptor modulators
10/19/2010US7816544 Use of an oxidopyrylium species as an intermediate in a chemical reaction; oxidopyrylium species is generated photochemically from a 3-hydroxychromone derivative followed by 1,3-dipolar cycloaddition of the oxidopyrylium species to a dipolarophile
10/14/2010WO2010115478A1 A process for manufacturing zeranol
10/14/2010WO2010089268A3 Process for preparing olopatadine and/or a pharmaceutically acceptable salt thereof
10/14/2010CA2742740A1 A process for manufacturing zeranol
10/13/2010CN1646473B Novel curcumin analogues and uses thereof
10/13/2010CN101861309A SALARIN and TULEARIN, compositions and uses thereof
10/07/2010WO2009105969A8 Epothilone analogues, their pharmaceutical compositions, their use and their preparations
10/07/2010US20100256398 Process for preparing epsilon-caprolactone
10/06/2010CN1872849B Method for synthesizing (S)(-)-gamma-lactone
10/06/2010CN101851244A Substituted phenyl keto enols as pesticides and herbicides
09/2010
09/30/2010US20100247475 Beta-glucuronidase inhibitor
09/29/2010EP2231635A1 Intermediates and methods for making zearalenone macrolide analogs
09/29/2010EP2231634A1 Intermediates in the synthesis of zearalenone macrolide analogs
09/29/2010CN101848904A Method for producing [epsilon]-caprolactone
09/28/2010US7803600 inhibitors of vacuolar-type H+-ATPase; antibiotic; (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16- [(1S,2R,3S)-3-[(2R,4R,5S,6R)-2,4-dihydroxy-6- isopropyl-5-methyl-2-tetrahydropyranyl]-2- hydroxy-1-methylbutyl]-8-hydroxy-3,15- dimethoxy-5,7,9,11-tetramethyl-1- oxacyclohexadeca-3,5,11,13-tetraen-2-one
09/23/2010US20100240913 Process for preparing epsilon-caprolactone
09/23/2010US20100240721 desoxyepothilone A and B; Fludelone; anticarcinogenic agents; drug resistance; water solubility for formulability; industrial scale; cytotoxic or growth inhibitory effects on CAG myeloma cells lines; ability to polymerize tubulin; minimum toxicity; stabilizing microtubules
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/16/2010US20100233279 Compositions And Methods Comprising Analogues Of Radicicol A
09/15/2010EP2228371A1 New process for preparing olopatadine free base and/or its hydrochloride salt
09/15/2010CN101830884A Macrolide as well as preparation method and antibacterial application thereof
09/09/2010US20100227917 EYE DROP CONTAINING DIBENZ[b,e]OXEPIN DERIVATIVE
09/09/2010US20100227916 N-desmethyl-doxepin and methods of using the same to treat sleep disorders
09/08/2010EP2225220A1 Method for producing -caprolactone
09/08/2010CN101824013A Maraniol with anti-cancer activity and preparation method thereof
09/01/2010EP2222690A2 Natural brassinosteroids for use for treating hyperproliferation, treating proliferative diseases and reducing adverse effects of steroid dysfunction in mammals, pharmaceutical composition and its use
08/2010
08/26/2010US20100216871 Use of compounds having ccr antagonism
08/25/2010EP2220041A1 Synthesis of quaternary salt compounds
08/25/2010CN101815709A Method for producing dibenzoxepin compound
08/25/2010CN101815708A Method for purification of dibenzoxepin compound
08/24/2010USRE41580 Lactone-containing compounds, polymers, resist compositions, and patterning method
08/24/2010US7781602 Derived from norbornadiene and hexafluoroacetone and has oxacyclopentane structure
08/18/2010EP2217587A1 Method for producing e-caprolactone
08/18/2010CN101809011A Macrocyclic lactones as fragrances
08/17/2010US7777084 Cyclopropanation process
08/12/2010WO2010089268A2 Process for preparing olopatadine and/or a pharmaceutically acceptable salt thereof
08/12/2010US20100204460 Natural brassinosteroids for use for treating hyperproliferation, treating proliferative diseases and reducing adverse effects of steroid dysfunction in mammals, pharmaceutical composition and its use
08/12/2010US20100204344 Macrocyclic Lactones as Fragrances
08/12/2010CA2746331A1 Process for preparing olopatadine and/or a pharmaceutically acceptable salt thereof
08/11/2010CN101157690B 1-thia-2- hydrocarbon imino-3,4-diaza-9- oxa (aza )-10-oxo spiro [4.15]-3- eicosanic, preparation method and usage as fungicide
08/05/2010WO2010087381A1 Process for producing dibenzoxepin compound
08/05/2010WO2010040843A3 Dibenzocycloheptanone derivatives and pharmaceutical agents containing said compounds
08/05/2010US20100197784 Novel curcumin analogues and uses thereof
08/04/2010EP2212286A1 Synthesis of quaternary salt compounds
07/2010
07/29/2010US20100190985 Heterodiamondoids
07/29/2010US20100189762 Triarylmethane analogs and their use in treating cancers
07/27/2010US7763740 aromatic diketo derivative which, as glucose 6-phosphatase translocase inhibitor, can be used in the treatment of diabetes mellitus
07/22/2010WO2010082684A1 Fragrance composition
07/22/2010WO2010082219A2 An arteether injection for treatment of malaria
07/22/2010US20100185014 Hydroxylation of Beta-Dicarbonyls with Zirconium Catalysts
07/21/2010CN101781280A Method for preparing color-stable epsilon-caprolactone
07/15/2010WO2010080577A2 Oxepine modulators of h1 receptors and/or inhibitors of mast cell degranulation
07/14/2010EP2206702A1 Bicyclic compound, production and use thereof
07/14/2010EP2205581A1 Macrocyclic lactones as fragrances
07/14/2010CN101778627A Multikinase inhibitors for use in the treatment of cancer
07/08/2010WO2010078396A2 Compounds, intermediates, and methods of preparing the same
07/06/2010US7750164 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 36